KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 4,710.00
+45.00 (0.96%)
At close: May 14, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 89.62 billion as of May 15, 2026. Its market cap has decreased by -17.88% in one year.
Market Cap
89.62B
Enterprise Value
73.25B
Revenue
69.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,710.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 89.62B, a decrease of -81.83%. That is a compound annual growth rate of -26.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 89.62B | -19.46% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 113.48B |
| NovMetaPharma | 112.36B |
| CHA Vaccine Research Institute | 99.67B |
| Choong Ang Vaccine Laboratory | 95.82B |
| TegoScience | 92.56B |
| SunBio,Inc. | 92.55B |
| CTCBIO | 92.53B |
| PanGen Biotech | 82.45B |